NRP2 and cancer: Further analysis showed that NRP2 was a risk factor in different cancers such as BLCA (HR 1.012, 95% CI 1.003-1.021, p = 0.0093), KICH (HR 1.178, 95% CI 1.008-1.375, p = 0.0390), KIRP (HR 1.048, 95% CI 1.015-1.081, p = 0.0040), LAML (HR 1.127, 95% CI 1.031-1.232, p = 0.0086), LGG (HR 1.012, 95% CI 1.002-1.021, p = 0.0168), LIHC (HR 1.015, 95% CI 1.001-1.029, p = 0.0400), MESO (HR 1.012, 95% CI 1.006-1.019, p = 0.0003), PAAD (HR 1.017, 95% CI 1.006-1.029, p = 0.0027), and STAD (HR 1.009, 95% CI 1.001-1.018, p = 0.0282) (Figure 3(b)).